Search the Newsreel

OppFi (OPFI) Earnings Date and Reports 2026

YPF Sociedad Anónima (NYSE:YPF) Given Consensus Rating of "Hold" by Brokerages

YPF Sociedad Anónima (NYSE:YPF) has received a consensus "Hold" rating from five brokerage firms, with three recommending a hold and two a buy. The average 12-month price target is $46.00, which is below its current share price of $49.20. Despite beating Q1 earnings expectations, …

Pfizer explores localisation, supply-chain and healthcare partnerships across Middle East, Africa

Pfizer is actively seeking manufacturing, technology transfer, research, and capability-building partnerships across the Middle East and Africa. This initiative responds to the region's growing demand for drug security and innovative therapies, driven by demographic growth and increased healthcare investment. The company aims to strengthen …

Stronger Earnings and Steady 2026 Guidance Might Change The Case For Investing In TechnipFMC (FTI)

TechnipFMC (FTI) reported stronger Q2 2026 results with increased revenue and net income, reaffirmed its full-year 2026 revenue guidance for its Subsea and Surface Technologies segments, and continued capital returns. These factors demonstrate management's confidence and support the near-term earnings catalyst, though the company's …

Solid Earnings Reflect TechnipFMC's (NYSE:FTI) Strength As A Business

TechnipFMC (NYSE:FTI) recently reported healthy earnings, but the stock price remained largely unchanged. An analysis of the company's financials reveals a strong accrual ratio of -0.14 for the year ending June 2026, indicating excellent cash conversion where free cash flow significantly exceeded reported profit. …

Biotechnology Stocks To Watch As Investors Look Past Pfizer’s Covid Revenue Drop

$OPFI Q2 2026 Earnings Preview: Recent $OPFI Insider Trading, Hedge Fund Activity, and More

Pfizer $44M settlement: How to know if you are included

Pfizer will pay $44 million to settle a class-action lawsuit concerning its smoking-cessation drug Chantix, which allegedly contained an undisclosed nitrosamine. The settlement covers U.S. individuals and third-party payors who purchased Chantix between September 29, 2015, and September 17, 2021. Claimants must file by …

Insider trades: Microsoft, Meta, Pfizer among notable names

[Meta European head office] Derick Hudson Insider transactions were seen across major firms this week, including Microsoft (MSFT [https://seekingalpha.com/symbol/MSFT]) and Meta (META [https://seekingalpha.com/symbol/META]). The following trades took place between August 3 and August 7. * Microsoft (MSFT [https://seekingalpha.com/symbol/MSFT]) saw two executives divest a small …

Insider trades: Microsoft, Meta, Pfizer among notable names (PFE:NYSE)

This article reports on notable insider trading activity that occurred between August 3 and August 7, 2026, involving several major companies. Executives at Microsoft and Meta divested portions of their holdings, while insider purchases were observed in companies like Pfizer, Taiwan Semiconductor, and Tilray …

Pfizer, Inc. (PFE) Stock Forecasts

Argus Senior Analyst David H. Toung has published a report on Pfizer Inc. (PFE), highlighting strong growth from the company's non-COVID products. The report provides a summary of Pfizer's position as a leading developer of pharmaceuticals and biotech drugs, including oncology, immunology, rare disease …

Pfizer Inc (PFE) Aktienanalyse & Prognose

How Hovnanian Enterprises Inc. Class A (HOV) Affects Rotational Strategy Timing

This article analyzes Hovnanian Enterprises Inc. Class A (HOV) using AI models to determine its effect on rotational strategy timing. It provides key findings such as near-term strong sentiment, a lack of clear price positioning, and compelling upside potential due to no remaining resistance …

Technical Reactions to FTI Trends in Macro Strategies

This article provides a technical analysis of Technipfmc Plc (NYSE: FTI), highlighting divergent sentiment across different time horizons and elevated downside risk due to a lack of long-term support signals. It outlines three AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—tailored for various …

Pfizer's Next Weight-Loss Weapon: How Berobenatide Stacks Up Against Novo Nordisk's Wegovy and Eli Lilly's Zepbound

Key Points Pfizer's berobenatide appears to be a promising candidate that could challenge Wegovy and Zepbound. There are several other reasons to consider the stock, despite the potential headwinds ahead. 10 stocks we like better than Pfizer › The past few years have been …

Análise e Previsão das Ações da Pfizer Inc (PFE)

Pfizer Inc. $PFE Shares Sold by Sarasin & Partners LLP

Sarasin & Partners LLP significantly reduced its stake in Pfizer Inc. by 37.7% in the second quarter of 2026, selling over 510,000 shares. Despite this, Pfizer reported strong Q2 earnings, exceeding analyst expectations for both EPS and revenue, and raised the low end of …

Pfizer Inc (PFE) Gewinnprognose: Zukünftige EPS & Umsatzwachstumsprognosen

How Pfizer Thinks About AI

Albert Bourla, CEO of Pfizer, outlines the company's ambition to be the most AI-forward in the pharmaceutical industry. He details three key strategies: structuring 177 years of data, federating AI across the organization to empower employees, and investing in AI fluency for all colleagues. …

Hovnanian Enterprises Inc (HOV) Earnings Forecast: Future EPS & Revenue Growth Estimates

The article provides an earnings forecast for Hovnanian Enterprises Inc (HOV), indicating its current earnings forecast score of 4.00 and an average price target of $120.00. Based on one analyst's rating, the stock has a "Sell" trend, with an expected next quarter EPS of …

Quantinno Capital Management LP Acquires 23,834 Shares of TechnipFMC plc $FTI

Quantinno Capital Management LP increased its stake in TechnipFMC plc by 40% in the first quarter, now holding 83,415 shares valued at $5.77 million. This move comes as TechnipFMC reported strong quarterly earnings, beating analyst estimates, and revenue grew 9% year-over-year. The company also …

TechnipFMC PLC (FTI) Aktuelle Aktien-News

AppFolio director Maurice Duca sells $2.54 million in company stock

AppFolio director Maurice Duca sold approximately $2.54 million worth of Class A Common Stock between August 4 and August 5, 2026, through a pre-arranged 10b5-1 trading plan. The sales involved 12,766 shares, both directly and indirectly through trusts. This comes as AppFolio reported a …

Global Influenza Vaccine Market Report, 2026 Edition - Profiles GlaxoSmithKline, Pfizer, Sanofi, Moderna, and 9 Other Players

Company Logo Dublin, Aug. 07, 2026 (GLOBE NEWSWIRE) -- The "Global Influenza Vaccine Market: 2026 Edition" has been added to ResearchAndMarkets.com's offering. The global influenza vaccine market was valued at US$8.96 billion in 2024 and is projected to reach US$13.32 billion by 2030, expanding …

Projeções de Resultados: TechnipFMC PLC (FTI) — LPA e Crescimento de Receita

Pfizer, Merck, Amgen Double Down On Cancer And Send Takeover Buzz Around SLS And IBRX Into Overdrive

Pfizer, Merck, and Amgen are expanding their cancer portfolios, leading to increased speculation about smaller oncology companies like Sellas Life Sciences (SLS) and ImmunityBio (IBRX) being potential acquisition targets. Pfizer's Seagen portfolio and Padcev, Merck's sac-TMT, and Amgen's T-cell engagers and Imdelltra are key …

FTI|TechnipFMC PLC|Price:69.620|Chg%:-0.030

Earnings To Watch: OppFi Inc (OPFI) Q2 2026 -- GF Value Sees 74% Downside

Warum die Pfizer-Aktie (PFE) trotz eines Nettoverlusts im zweiten Quartal um 5,2 % gestiegen ist, nachdem das Unternehmen seine Prognose für 2026 angehoben hat

Why Pfizer (PFE) Is Up 5.2% After Raising 2026 Guidance Despite a Q2 Net Loss

Hovnanian Enterprises schedules fiscal Q3 earnings release and conference call

Hovnanian Enterprises (NYSE: HOV) announced its fiscal Q3 2026 earnings release and conference call. The company will release results for the period ended July 31, 2026, on August 20, 2026, with the conference call scheduled for 11:00 a.m. ET on the same day via …

Novavax Inc (NVAX) (Q2 2026) Earnings Call Highlights: Matrix-M Momentum Drives Revenue ...

This article first appeared on GuruFocus. Release Date: August 06, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Novavax Inc (NASDAQ:NVAX) has secured licensing or material transfer agreements with 4 of the TOP10 …

Pfizer Inc Earnings Call Signals Cautious Optimism

Pfizer Inc.'s Q2 earnings call revealed cautious optimism, with core revenues and adjusted EPS surpassing expectations, leading to raised full-year revenue guidance. The company demonstrated strong performance in oncology and neuroscience, alongside significant R&D activity, despite setbacks from a clinical trial miss, weaker COVID …

Pfizer shares rise after strong Q2 earnings des...

GMM Pfaudler Q1 Results: Earnings call audio released for Q1FY27

Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), Ultragenyx Pharmaceutical (RARE) and Allogene Therapeutics (ALLO)

This article provides analyst ratings and price targets for three healthcare companies: Pfizer (PFE), Ultragenyx Pharmaceutical (RARE), and Allogene Therapeutics (ALLO). Citi analyst Geoff Meacham maintained a Hold rating on Pfizer, while Citi analyst Yigal Nochomovitz maintained a Buy rating on Ultragenyx Pharmaceutical. William …